SLT Outperforms Medications in Reducing Glaucoma Progression…study shows
The recent report from the American Academy of Ophthalmology makes a compelling case for selecting Selective Laser Trabeculoplasty (SLT) as a preferred first-line treatment for primary open-angle glaucoma (POAG). As shown in the LiGHT trial, SLT is not only effective but significantly reduces disease progression risk when compared to topical medications. Findings of this study […]
SLT Outperforms Medications in Reducing Glaucoma Progression…study shows Read More »